ClinicalTrials.gg
CompletedNCT06906458Updated Nov 17, 2025

Impact of Paresthesia on Postoperative Neurological Symptoms

An observational study in Interscalene Block and Postoperative Pain, sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-11-17.

Sponsored by Ankara City Hospital Bilkent · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
120
Ages
18 Years to 65 Years
Sex
All
01

Study summary

In this study, the effect of paresthesia occurring during the interscalene block procedure on the incidence of postoperative neurological symptoms will be investigated. Paresthesia is defined as an abnormal sensation described as "tingling, pinprick, severe pain, or an electric feeling in the arm." The status of postoperative neurological symptoms in patients at the end of the block's effective duration will be assessed through phone interviews, evaluating symptoms such as arm numbness, tingling, abnormal sensations, pain, and weakness.

Read the detailed description

Our study includes patients aged 18-65 years with American Society of Anesthesiologists (ASA) physical status I or II who undergo interscalene nerve block prior to arthroscopic shoulder surgery under general anesthesia. All patients will be fasting according to standard protocol. During the preoperative period, patients' age, comorbidities, gender, body mass index (BMI), ASA scores, and preoperative Quality of Recovery-15 (QoR-15) scores will be recorded.

In the operating room, possible complications related to the block (paresthesia, Horner's syndrome, dyspnea, hoarseness) will be monitored in the preoperative area. During the intraoperative period, data such as pulse, blood pressure, infusion fluids, intraoperative remifentanil requirements, anesthesia duration, and surgical time will be recorded.

In the postoperative period, postoperative pain status, block duration, postoperative nausea and vomiting, need for rescue analgesics and antiemetics, and QoR-15 scores on the first day will be assessed in the recovery room and ward. Additionally, postoperative neurological symptoms and QoR-15 scores will be followed via telephone on the 3rd, 7th, 10th, and 30th days after discharge.

For patients developing postoperative pain, pain intensity will be evaluated using an 11-point numeric rating scale, where 0 indicates no symptoms and 10 represents maximum severity.

02

Conditions studied

  • Interscalene Block
  • Postoperative Pain

Keywords

  • Interscalene block
  • Paresthesia
  • Postoperative neurological symptoms
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's enrollment of 120 is above the median of 102 across 683 observational studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Ankara City Hospital Bilkent is the lead sponsor of 443 studies on the registry; 111 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study will include patients aged 18-65 years with ASA physical status I or II who are planned to undergo interscalene nerve block for analgesia prior to arthroscopic shoulder surgery in the beach chair position under general anesthesia.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • I to II
  • Age range of 18-65 years
  • Patients planned for interscalene nerve block for analgesia prior to arthroscopic shoulder surgery in the beach chair position under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • >35 kg/m²)
  • history of drug use
  • Patient's refusal to participate in the study
  • Psychiatric disorders
  • Central nervous system diseases
  • Vestibular disorders
  • Presence of diabetes, neuropathy, and paralysis
  • Pregnancy
  • Open shoulder surgery
  • Allergy to local anesthetics
  • Coagulopathy
  • Severe thrombocytopenia
  • Infection at the puncture site
  • Pre-existing neuropathy in the limb to be operated on
  • Use of opioid and antiemetic medications before surgery
  • Use of dexamethasone
  • Lung disease
  • Low baseline oxygen saturation
  • Patients who cannot cooperate in the postoperative period (e.g., mental retardation, delirium, language acquisition deficiency, etc.)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
120 participants (actual)
Patient registry
No

Groups and cohorts

  • Paresthesia

    Patients experiencing paresthesia during the interscalene nerve block

    Other: Paresthesia

  • No paresthesia

    Patients not experiencing paresthesia during the interscalene nerve block

    Other: No paresthesia

Interventions

  • OtherParesthesia

    Patients experiencing paresthesia during the interscalene nerve block

  • OtherNo paresthesia

    Patients not experiencing paresthesia during the interscalene nerve block

06

What researchers measure

Primary outcomes

  1. Paresthesia incidence

    Paresthesia is considered an abnormal sensation described as "tingling, pinprick, severe pain, or an electric feeling in the arm." When paresthesia occurs, the block procedure will be halted, and the needle will be redirected; local anesthetic will not be administered until the paresthesia resolves, and the occurrence of paresthesia will be recorded.

    Time frame: Perioperative time

Secondary outcomes

  1. Incidence of postoperative neurological symptoms

    the status of postoperative neurological symptoms will be assessed via telephone by a physician different from the one who performed the block. During the evaluation, symptoms such as arm numbness, tingling, abnormal sensations, pain, and weakness will be considered. Those responding "yes" to any of these symptoms will be classified as patients experiencing postoperative neurological symptoms.

    Time frame: 30 days

  2. Postoperative pain

    In the postoperative period, patients will be assessed for pain using a 0-10 Numeric Rating Scale (NRS) at rest at 4, 6, 8, 12, 16, and 18 hours, and at both rest and during movement at 24 and 36 hours to record the highest pain scores. The NRS is a scale used for patients to express their pain levels, where 0 represents the absence of pain and 10 represents the most severe pain.

    Time frame: 36 hours

  3. Duration of block effectiveness

    The time (in minutes) until the patient reports a significant increase in pain after the block

    Time frame: 36 hours

  4. Postoperative nausea and vomiting

    Significant nausea, vomiting, and/or need for rescue antiemetics

    Time frame: 36 hours

  5. Rescue analgesic requirement

    Number of additional analgesic applications

    Time frame: 36 hours

  6. Rescue antiemetic requirement

    Number of additional antiemetic applications

    Time frame: 36 hours

  7. intraoperative opioid requirement

    To maintain the bispectral index (BIS) between 40-60, remifentanil will be initiated and titrated between 0.05-0.25 mcg/kg/min, taking into account a 20% increase in MAP (mean arterial pressure) compared to the initial value and a 15% increase in heart rate compared to the initial value.

    Time frame: intraoperative time

  8. Duration of stay in the recovery room

    The time from arrival in the recovery room until the discharge criteria are met

    Time frame: 2 hours

  9. Quality of Recovery-15 (QoR-15) scores

    The QoR-15 questionnaire consists of 15 questions rated on a scale of 0 to 10, with a total score assessed out of 150. Results are classified as follows: above 135 is considered "excellent," 122-135 is "good," 90-121 is "fair," and below 90 is "poor.

    Time frame: 30 days

  10. Horner's syndrome

    Miosis and ptosis of the ipsilateral pupil during the perioperative period.

    Time frame: Perioperative/Periprocedural

  11. Dyspnea

    Breathing difficulty as described by the patient during the perioperative period.

    Time frame: Perioperative/Periprocedural

  12. Hoarseness

    Voice changes described by the patient during the perioperative period

    Time frame: Perioperative/Periprocedural

07

Study locations

1 site
  • Ankara Bilkent City Hospital
    Ankara, Ankara, Çankaya 06800, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2025 to primary completion in Sep 2025, 5 months.

Of 391 non-industry observational studies under Pain, Postoperative, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's 5 months is below that.

Counting every sponsor, half of 395 studies reached it within 13 months; a quarter within 5 and three quarters within 33.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2025
First posted
Apr 2, 2025
StartActual
Apr 11, 2025
Primary completionActual
Sep 15, 2025
CompletionActual
Oct 20, 2025
Last update
Nov 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06906458
Responsible party
Gökhan Erdem (Anesthesiology and Reanimation specialist doctor, Ankara City Hospital Bilkent) — Principal investigator
First posted
Apr 2, 2025
Start date
Apr 11, 2025
Primary completion
Sep 15, 2025
Completion
Oct 20, 2025
Last update
Nov 17, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion